Why is Johnson Pharma falling/rising?

As of 08-Oct, Johnson Pharmacare Ltd's stock price is currently at Rs. 0.74, reflecting a decrease of Rs. 0.01 or 1.33%. The stock has recently hit a new 52-week low of Rs. 0.72 and has underperformed its sector by 0.38%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has declined by 3.90%, and year-to-date, it has seen a significant drop of 35.09%. The delivery volume has also decreased by 4.29% compared to the 5-day average, suggesting a decline in investor participation, which may further contribute to the downward pressure on the stock.
In the broader market context, the Sensex has shown a positive return of 0.98% over the past week, contrasting sharply with Johnson Pharma's negative performance. This divergence indicates that while the overall market is experiencing gains, Johnson Pharma is struggling significantly. The stock's year-to-date performance is notably poor compared to the Sensex's 4.65% increase, highlighting a lack of investor confidence in Johnson Pharma relative to the market. Overall, the combination of declining stock performance, reduced investor participation, and unfavorable comparisons to the benchmark suggests that Johnson Pharma is facing challenges that are contributing to its falling stock price.